Share on StockTwits

Shares of ArthroCare (NASDAQ:ARTC) were the target of a significant growth in short interest in April. As of April 30th, there was short interest totalling 927,529 shares, a growth of 35.6% from the April 15th total of 684,154 shares, American Banking & Market News reports. Based on an average daily trading volume, of 565,477 shares, the days-to-cover ratio is presently 1.6 days. Currently, 3.3% of the company’s stock are sold short.

ARTC has been the subject of a number of recent research reports. Analysts at TheStreet downgraded shares of ArthroCare from a “buy” rating to a “hold” rating in a research note on Tuesday, May 6th. Separately, analysts at JMP Securities downgraded shares of ArthroCare to a “market perform” rating in a research note on Thursday, March 6th. Finally, analysts at William Blair downgraded shares of ArthroCare from an “outperform” rating to a “market perform” rating in a research note on Thursday, March 6th. Six analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus target price of $49.67.

ArthroCare (NASDAQ:ARTC) opened at 48.53 on Monday. ArthroCare has a 52 week low of $31.56 and a 52 week high of $49.95. The stock has a 50-day moving average of $48.45 and a 200-day moving average of $44.46. The company has a market cap of $1.674 billion and a price-to-earnings ratio of 110.34.

ArthroCare (NASDAQ:ARTC) last issued its quarterly earnings data on Friday, May 2nd. The company reported $0.32 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.36 by $0.04. The company had revenue of $96.06 million for the quarter, compared to the consensus estimate of $96.00 million. During the same quarter last year, the company posted $0.30 earnings per share. ArthroCare’s revenue was up 4.0% compared to the same quarter last year. On average, analysts predict that ArthroCare will post $1.50 earnings per share for the current fiscal year.

ArthroCare Corporation (NASDAQ:ARTC), is a medical device company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.